Skip to main content
. 2018 Apr 12;15(6):4599–4614. doi: 10.3892/etm.2018.6053

Figure 7.

Figure 7.

Protective effects of Sal on ConA-induced liver injury may be reversed by LY294002, a PI3K inhibitor. (A) Serum liver enzyme levels. (B) Relative mRNA levels of TNF-α, IL-6, Bcl-2, Bax, beclin-1 and LC3. (C and D) Protein expression of p-Akt, TNF-α, IL-6, Bcl-2, Bax, beclin-1, LC3 and β-actin. β-actin was used as the internal control. Data are presented as the mean + standard deviation (n=6). *P<0.05 vs. NC; ξP<0.05 vs. ConA; P<0.05 vs. ConA + Sal. Sal, salidroside; ConA, concanavalin A; NC, negative control; ALT, alanine aminotransferase; AST, aspartate aminotransferase; IL, interleukin; TNF-α, tumor necrosis factor-α; Bcl-2, B-cell lymphoma-2; Bax, Bcl-2-associated X protein; LC3, microtubule-associated protein 1A/1B-light chain 3; p-, phosphorylated.